# Guangdong Academy of Medical Sciences

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/guangdong-academy-of-medical-sciences/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 44 |
| Citations | 1,142,565 |
| City | Guangzhou |
| Country | CN |
| Description | Guangdong Academy of Medical Sciences is a research organisation in Guangzhou, CN. OpenAlex records 17,135 works and 1,142,565 citations for it. 7,305 researchers list it as their most recent affiliation. |
| Homepage | http://www.gdghospital.org.cn/ |
| OpenAlex ID | https://openalex.org/I4210145693 |
| Region | Guangdong |
| Researchers | 7,305 |
| ROR ID | https://ror.org/0432p8t34 |
| Type | healthcare |
| Works | 17,135 |

## University papers

Showing 12 of 64.

- [Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis](https://scholariq.org/papers/comorbidity-and-its-impact-on-1590-patients-with-covid-19-in-china-a-nationwide/)
- [Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial](https://scholariq.org/papers/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo/)
- [Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial](https://scholariq.org/papers/afatinib-versus-cisplatin-plus-gemcitabine-for-first-line-treatment-of-asian/)
- [Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension](https://scholariq.org/papers/macitentan-and-morbidity-and-mortality-in-pulmonary-arterial-hypertension/)
- [Riociguat for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/riociguat-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma](https://scholariq.org/papers/potential-predictive-value-of-i-tp53-i-and-i-kras-i-mutation-status-for-response/)
- [Updated Treatment Algorithm of Pulmonary Arterial Hypertension](https://scholariq.org/papers/updated-treatment-algorithm-of-pulmonary-arterial-hypertension/)
- [Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis](https://scholariq.org/papers/comorbidity-and-its-impact-on-1-590-patients-with-covid-19-in-china-a-nationwide/)
- [Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers](https://scholariq.org/papers/complications-of-right-heart-catheterization-procedures-in-patients-with/)
- [Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study](https://scholariq.org/papers/gefitinib-versus-vinorelbine-plus-cisplatin-as-adjuvant-treatment-for-stage-ii/)
- [Clinical features of paediatric pulmonary hypertension: a registry study](https://scholariq.org/papers/clinical-features-of-paediatric-pulmonary-hypertension-a-registry-study/)
- [EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer](https://scholariq.org/papers/egfr-mutation-correlates-with-uninflamed-phenotype-and-weak-immunogenicity/)

## University researchers

- [Wen‐Zhao Zhong](https://scholariq.org/researchers/wen-zhao-zhong/)
- [Xu‐Chao Zhang](https://scholariq.org/researchers/xu-chao-zhang/)
- [Jin‐Ji Yang](https://scholariq.org/researchers/jin-ji-yang/)
- [Chong‐Rui Xu](https://scholariq.org/researchers/chong-rui-xu/)
- [Hao Dai](https://scholariq.org/researchers/hao-dai/)
- [Huan Ma](https://scholariq.org/researchers/huan-ma/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.